BUNKER KEVIN D. (Chief Operating Officer) sold 3.6% of their position (5K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $152.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/13/2022ACC: 0001725160-22-000078
Officer· Chief Operating Officer
Since Apr 2020
-5K
Net shares
Net seller
$152.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
5K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−4.60K
Price / share
$30.37
Trade value
$139.71K
% of position
3.3%
4/11/2022
140K→135.40K
Common Stock
Indirect
Shares
−300.00
Price / share
$32.40
Trade value
$9.72K
% of position
0.2%
4/11/2022
135.40K→135.10K
Common Stock
Indirect
Shares
−100.00
Price / share
$33.16
Trade value
$3.32K
% of position
0.1%
4/11/2022
135.10K→135K
Total
Net shares
−5K
Net value
-$152.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/11/2022 | S · Sale | −4.60K | $30.37 | $139.71K | 3.3% | 140K | 135.40K |
| Common Stock Indirect | 4/11/2022 | S · Sale | −300.00 | $32.40 | $9.72K | 0.2% | 135.40K | 135.10K |
| Common Stock Indirect | 4/11/2022 | S · Sale | −100.00 | $33.16 | $3.32K | 0.1% | 135.10K | 135K |
| Total | −5K | -$152.74K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned764.11K
Common Stock
IndirectShares owned350.00
Total
764.11K direct·350.00 indirect764.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 764.11K | Direct |
| Common Stock | 350.00 | Indirect |
| Total | 764.46K | 764.11K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported